XML 24 R43.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisition - Additional Information (Detail) (Crescendo Biosciences, Inc., USD $)
0 Months Ended
Feb. 28, 2014
Business Acquisition [Line Items]  
Total consideration transferred $ 258,950,000us-gaap_BusinessCombinationConsiderationTransferred1
Business acquisition, cash transferred 225,100,000us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Elimination of intercompany balances related to accrued interest and term loan 25,900,000mygn_BusinessCombinationConsiderationTransferredEliminationOfIntercompanyBalancesRelatedToAccruedInterestAndTermLoan
Fair value of purchase option granted 8,000,000mygn_BusinessCombinationConsiderationTransferredFairValuePurchaseOption
Business acquisition, amount deposited into escrow account 20,000,000mygn_BusinessAcquisitionConsiderationCashDepositedEscrowAccount
Share-based compensation to Crescendo employees 6,929,000mygn_BusinessCombinationConsiderationTransferredSharebasedCompensation
Control bonuses paid to Crescendo employees $ 5,695,000mygn_BusinessCombinationConsiderationTransferredChangeOfControlPayments
Minimum
 
Business Acquisition [Line Items]  
Period of audit completion 12 months
Maximum
 
Business Acquisition [Line Items]  
Period of audit completion 15 months